Bulletin of Experimental Biology and Medicine

, Volume 164, Issue 6, pp 766–769 | Cite as

Effect of Nanocrystalline Particles of Chitin on Blood Components in Humans and Experimental Animals

  • N. N. Drozd
  • M. A. Torlopov
  • E. V. Udoratina
  • Yu. S. Logvinova

Nanocrystalline particles of chitin in the form of hydrosol in a concentration of 0.63 mg/ml have no effect on aggregation of human platelets and clotting time of platelet-poor plasma in coagulation tests. ADP-induced aggregation of human platelets was inhibited by these nanoparticles in concentrations of 0.63 and 1.00 mg/ml in comparison with the control. Intravenous administration of nanoparticles in a dose of 1 mg/kg to guinea pigs produced no anticoagulant effect. The nanocrystalline particles of chitin can be of interest as potential drug delivery systems.

Key Words

chitin nanoparticles plasma/blood clotting 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bender EA, Adorne MD, Colomé LM, Abdalla DS, Guterres SS, Pohlmann AR. Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan. Int. J. Pharm. 2012;426(1-2):271-279.CrossRefPubMedGoogle Scholar
  2. 2.
    Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927-929.CrossRefPubMedGoogle Scholar
  3. 3.
    Cardénas G, Cabrera G, Taboada E, Miranda SP. Chitin characterization by SEM, FTIR, XRD, and 13C cross polarization/ mass angle spinning NMR. J. Appl. Pol. Sci. 2004;93(4):1876-1885. doi: Scholar
  4. 4.
    Chen C, Li D, Yano H, Abe K. Dissolution and gelation of α-chitin nanofibers using a simple NaOH treatment at low temperatures. Cellulose. 2014;21(5):3339-3346.CrossRefGoogle Scholar
  5. 5.
    Cheng J, Feng S, Han S, Zhang X, Chen Y, Zhou X, Wang R, Li X, Hu H, Zhang J. Facile assembly of cost-effective and locally applicable or injectable nanohemostats for hemorrhage control. ACS Nano. 2016;10(11):9957-9973.CrossRefPubMedGoogle Scholar
  6. 6.
    Ding F, Deng H, Du Y, Shi X, Wang Q. Emerging chitin and chitosan nanofibrous materials for biomedical applications. Nanoscale. 2014;6(16):9477-9493.CrossRefPubMedGoogle Scholar
  7. 7.
    Fornaguera C, Solans C. Methods for the in vitro characterization of nanomedicines-biological component interaction. J. Pers Med. 2017;7(1). pii: E2. doi:
  8. 8.
    Ilinskaya AN, Dobrovolskaia MA. Nanoparticles and the blood coagulation system. Part II: safety concerns. Nanomedicine (Lond). 2013;8(6):969-981.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Islam N, Ferro V. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery. Nanoscale. 2016;8(30):14 341-14 358.CrossRefGoogle Scholar
  10. 10.
    Kim ES, Lee JS, Lee HG. Nanoencapsulation of red ginseng extracts using chitosan with polyglutamic acid or fucoidan for improving antithrombotic activities. J. Agric. Food Chem. 2016;64(23):4765-4771.CrossRefPubMedGoogle Scholar
  11. 11.
    Pereira AG, Muniz EC, Hsieh YL. Chitosan-sheath and chitin-core nanowhiskers. Carbohydr. polym. 2014;107:158-166.CrossRefPubMedGoogle Scholar
  12. 12.
    Simon TL, Hyers TM, Gaston JP, Harker LA. Heparin pharmacokinetics increased requirements in pulmonary embolism. Br. J. Haematol. 1978;39(1):111-120.CrossRefPubMedGoogle Scholar
  13. 13.
    Sithole MN, Choonara YE, du Toit LC, Kumar P, Pillay V. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability. Pharm. Dev. Technol. 2017;22(2):283-295.CrossRefPubMedGoogle Scholar
  14. 14.
    Song L, Zhu D, Liu L, Dong X, Zhang H, Leng X. Evaluation of the coagulation properties of arginine-chitosan/DNA nanoparticles. J. Biomed. Mater. Res. B Appl. Biomater. 2010;95(2):374-379.CrossRefPubMedGoogle Scholar
  15. 15.
    Zeng JB, He YS, Li SL, Wang YZ. Chitin whiskers: an overview. Biomacromolecules. 2012;13(1):1-11.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • N. N. Drozd
    • 1
  • M. A. Torlopov
    • 2
  • E. V. Udoratina
    • 2
  • Yu. S. Logvinova
    • 1
  1. 1.Hematology Research CenterMinistry of Health of the Russian FederationMoscowRussia
  2. 2.Institute of Chemistry of Komi Research CenterUral Division of Russian Academy of ScienceSyktyvkarRussia

Personalised recommendations